HK1215178A1 - 種利福霉素-硝基咪唑偶聯分子的新用途 - Google Patents

種利福霉素-硝基咪唑偶聯分子的新用途

Info

Publication number
HK1215178A1
HK1215178A1 HK16103194.0A HK16103194A HK1215178A1 HK 1215178 A1 HK1215178 A1 HK 1215178A1 HK 16103194 A HK16103194 A HK 16103194A HK 1215178 A1 HK1215178 A1 HK 1215178A1
Authority
HK
Hong Kong
Prior art keywords
rifamycin
nitroimidazole
new use
hybrid molecule
hybrid
Prior art date
Application number
HK16103194.0A
Other languages
English (en)
Inventor
馬振坤
格雷戈瑞‧羅伯森
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1215178A1 publication Critical patent/HK1215178A1/zh

Links

HK16103194.0A 2015-06-09 2016-03-18 種利福霉素-硝基咪唑偶聯分子的新用途 HK1215178A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510313301.4A CN104971061B (zh) 2015-06-09 2015-06-09 一种利福霉素‑硝基咪唑偶联分子的用途

Publications (1)

Publication Number Publication Date
HK1215178A1 true HK1215178A1 (zh) 2016-08-19

Family

ID=54268383

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16103194.0A HK1215178A1 (zh) 2015-06-09 2016-03-18 種利福霉素-硝基咪唑偶聯分子的新用途

Country Status (2)

Country Link
CN (1) CN104971061B (zh)
HK (1) HK1215178A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106860451A (zh) * 2017-02-28 2017-06-20 丹诺医药(苏州）有限公司 一种利福霉素‑硝基咪唑偶联分子的新应用
CN106822119A (zh) * 2017-02-28 2017-06-13 丹诺医药(苏州）有限公司 一种利福霉素‑硝基咪唑偶联分子的新用途
CN108047250B (zh) * 2018-02-12 2020-08-14 丹诺医药(苏州）有限公司 一种利福霉素-硝基咪唑偶联分子的应用
CN109464673A (zh) * 2019-01-08 2019-03-15 丹诺医药(苏州）有限公司 利福霉素-喹嗪酮偶联分子及其盐的应用和制剂
WO2024036578A1 (en) * 2022-08-18 2024-02-22 Tennor Therapeutics (Suzhou) Limited Methods for preventing or treating h. pylori infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008008480A2 (en) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
CN103360370A (zh) * 2012-04-06 2013-10-23 南京大学 硝基咪唑衍生物的合成及其在抗菌药物方面的应用
CN104086534B (zh) * 2014-07-29 2016-07-06 西南大学 喹诺酮唑醇类化合物及其制备方法和应用

Also Published As

Publication number Publication date
CN104971061B (zh) 2017-11-07
CN104971061A (zh) 2015-10-14

Similar Documents

Publication Publication Date Title
EP3267015A4 (en) Hybrid construction machine
HK1215178A1 (zh) 種利福霉素-硝基咪唑偶聯分子的新用途
HK1245269A1 (zh) 咪唑衍生物
EP3249116A4 (en) Hybrid construction machine
HK1215252A1 (zh) 種利福霉素-硝基咪唑偶聯分子的製備方法
EP3386571C0 (en) T-SHAPED CAP FOR MEDICAL INJECTOR
EP3342940A4 (en) HYBRID CONSTRUCTION EQUIPMENT
EP3249115A4 (en) Hybrid construction machine
EP3393609A4 (en) RACKET-SKI HYBRID
SG11201700029RA (en) Hybrid primer
AU2014117V (en) Calkwr Callistemon hybrid
AU5370P (en) SRA3 Saccharum hybrid
AU5359P (en) SRA4 Saccharum hybrid
AU5573P (en) SRA6 Saccharum hybrid
AU5571P (en) SRA5 Saccharum hybrid
AU5574P (en) SRA7 Saccharum hybrid
AU5611P (en) Manevered Mandevilla hybrid
AU5552P (en) USEVO1201 Evolvulus hybrid
AU2016349V (en) AMBIC001 Agapanthus hybrid
AU2016211V (en) QC04-1411 Saccharum hybrid
AU2016207V (en) QS05-6092 Saccharum hybrid
AU5369P (en) SRA2 Saccharum hybrid
AU2015230V (en) AGA04051 Agapanthus hybrid
AU2015227V (en) PWBC7 Chamelaucium hybrid
AU2015096V (en) KP02 Anigozanthos hybrid